Cargando…

Formulation Development, Optimization by Box–Behnken Design, and In Vitro and Ex Vivo Characterization of Hexatriacontane-Loaded Transethosomal Gel for Antimicrobial Treatment for Skin Infections

There are many different infections and factors that can lead to skin illnesses, but bacteria and fungi are the most frequent. The goal of this study was to develop a hexatriacontane-loaded transethosome (HTC-TES) for treating skin conditions caused by microbes. The HTC-TES was developed utilizing t...

Descripción completa

Detalles Bibliográficos
Autores principales: Aodah, Alhussain H., Hashmi, Sana, Akhtar, Naseem, Ullah, Zabih, Zafar, Ameeduzzafar, Zaki, Randa Mohammed, Khan, Shamshir, Ansari, Mohammad Javed, Jawaid, Talha, Alam, Aftab, Ali, Md Sajid
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10137727/
https://www.ncbi.nlm.nih.gov/pubmed/37102934
http://dx.doi.org/10.3390/gels9040322
_version_ 1785032536524587008
author Aodah, Alhussain H.
Hashmi, Sana
Akhtar, Naseem
Ullah, Zabih
Zafar, Ameeduzzafar
Zaki, Randa Mohammed
Khan, Shamshir
Ansari, Mohammad Javed
Jawaid, Talha
Alam, Aftab
Ali, Md Sajid
author_facet Aodah, Alhussain H.
Hashmi, Sana
Akhtar, Naseem
Ullah, Zabih
Zafar, Ameeduzzafar
Zaki, Randa Mohammed
Khan, Shamshir
Ansari, Mohammad Javed
Jawaid, Talha
Alam, Aftab
Ali, Md Sajid
author_sort Aodah, Alhussain H.
collection PubMed
description There are many different infections and factors that can lead to skin illnesses, but bacteria and fungi are the most frequent. The goal of this study was to develop a hexatriacontane-loaded transethosome (HTC-TES) for treating skin conditions caused by microbes. The HTC-TES was developed utilizing the rotary evaporator technique, and Box–Behnken design (BBD) was utilized to improve it. The responses chosen were particle size (nm) (Y1), polydispersity index (PDI) (Y2), and entrapment efficiency (Y3), while the independent variables chosen were lipoid (mg) (A), ethanol (%) (B), and sodium cholate (mg) (C). The optimized TES formulation with code F1, which contains lipoid (mg) (A) 90, ethanol (%) (B) 25, and sodium cholate (mg) (C) 10, was chosen. Furthermore, the generated HTC-TES was used for research on confocal laser scanning microscopy (CLSM), dermatokinetics, and in vitro HTC release. The results of the study reveal that the ideal formulation of the HTC-loaded TES had the following characteristics: 183.9 nm, 0.262 mV, −26.61 mV, and 87.79% particle size, PDI, and entrapment efficiency, respectively. An in vitro study on HTC release found that the rates of HTC release for HTC-TES and conventional HTC suspension were 74.67 ± 0.22 and 38.75 ± 0.23, respectively. The release of hexatriacontane from TES fit the Higuchi model the best, and the Korsmeyer–Peppas model indicates the release of HTC followed a non-Fickian diffusion. By having a higher negative value for cohesiveness, the produced gel formulation demonstrated its stiffness, whereas good spreadability indicated better gel application to the surface. In a dermatokinetics study, it was discovered that TES gel considerably increased HTC transport in the epidermal layers (p < 0.05) when compared to HTC conventional formulation gel (HTC-CFG). The CLSM of rat skin treated with the rhodamine B-loaded TES formulation demonstrated a deeper penetration of 30.0 µm in comparison to the hydroalcoholic rhodamine B solution (0.15 µm). The HTC-loaded transethosome was determined to be an effective inhibitor of pathogenic bacterial growth (S. aureus and E. coli) at a concentration of 10 mg/mL. It was discovered that both pathogenic strains were susceptible to free HTC. According to the findings, HTC-TES gel can be employed to enhance therapeutic outcomes through antimicrobial activity.
format Online
Article
Text
id pubmed-10137727
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-101377272023-04-28 Formulation Development, Optimization by Box–Behnken Design, and In Vitro and Ex Vivo Characterization of Hexatriacontane-Loaded Transethosomal Gel for Antimicrobial Treatment for Skin Infections Aodah, Alhussain H. Hashmi, Sana Akhtar, Naseem Ullah, Zabih Zafar, Ameeduzzafar Zaki, Randa Mohammed Khan, Shamshir Ansari, Mohammad Javed Jawaid, Talha Alam, Aftab Ali, Md Sajid Gels Article There are many different infections and factors that can lead to skin illnesses, but bacteria and fungi are the most frequent. The goal of this study was to develop a hexatriacontane-loaded transethosome (HTC-TES) for treating skin conditions caused by microbes. The HTC-TES was developed utilizing the rotary evaporator technique, and Box–Behnken design (BBD) was utilized to improve it. The responses chosen were particle size (nm) (Y1), polydispersity index (PDI) (Y2), and entrapment efficiency (Y3), while the independent variables chosen were lipoid (mg) (A), ethanol (%) (B), and sodium cholate (mg) (C). The optimized TES formulation with code F1, which contains lipoid (mg) (A) 90, ethanol (%) (B) 25, and sodium cholate (mg) (C) 10, was chosen. Furthermore, the generated HTC-TES was used for research on confocal laser scanning microscopy (CLSM), dermatokinetics, and in vitro HTC release. The results of the study reveal that the ideal formulation of the HTC-loaded TES had the following characteristics: 183.9 nm, 0.262 mV, −26.61 mV, and 87.79% particle size, PDI, and entrapment efficiency, respectively. An in vitro study on HTC release found that the rates of HTC release for HTC-TES and conventional HTC suspension were 74.67 ± 0.22 and 38.75 ± 0.23, respectively. The release of hexatriacontane from TES fit the Higuchi model the best, and the Korsmeyer–Peppas model indicates the release of HTC followed a non-Fickian diffusion. By having a higher negative value for cohesiveness, the produced gel formulation demonstrated its stiffness, whereas good spreadability indicated better gel application to the surface. In a dermatokinetics study, it was discovered that TES gel considerably increased HTC transport in the epidermal layers (p < 0.05) when compared to HTC conventional formulation gel (HTC-CFG). The CLSM of rat skin treated with the rhodamine B-loaded TES formulation demonstrated a deeper penetration of 30.0 µm in comparison to the hydroalcoholic rhodamine B solution (0.15 µm). The HTC-loaded transethosome was determined to be an effective inhibitor of pathogenic bacterial growth (S. aureus and E. coli) at a concentration of 10 mg/mL. It was discovered that both pathogenic strains were susceptible to free HTC. According to the findings, HTC-TES gel can be employed to enhance therapeutic outcomes through antimicrobial activity. MDPI 2023-04-11 /pmc/articles/PMC10137727/ /pubmed/37102934 http://dx.doi.org/10.3390/gels9040322 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Aodah, Alhussain H.
Hashmi, Sana
Akhtar, Naseem
Ullah, Zabih
Zafar, Ameeduzzafar
Zaki, Randa Mohammed
Khan, Shamshir
Ansari, Mohammad Javed
Jawaid, Talha
Alam, Aftab
Ali, Md Sajid
Formulation Development, Optimization by Box–Behnken Design, and In Vitro and Ex Vivo Characterization of Hexatriacontane-Loaded Transethosomal Gel for Antimicrobial Treatment for Skin Infections
title Formulation Development, Optimization by Box–Behnken Design, and In Vitro and Ex Vivo Characterization of Hexatriacontane-Loaded Transethosomal Gel for Antimicrobial Treatment for Skin Infections
title_full Formulation Development, Optimization by Box–Behnken Design, and In Vitro and Ex Vivo Characterization of Hexatriacontane-Loaded Transethosomal Gel for Antimicrobial Treatment for Skin Infections
title_fullStr Formulation Development, Optimization by Box–Behnken Design, and In Vitro and Ex Vivo Characterization of Hexatriacontane-Loaded Transethosomal Gel for Antimicrobial Treatment for Skin Infections
title_full_unstemmed Formulation Development, Optimization by Box–Behnken Design, and In Vitro and Ex Vivo Characterization of Hexatriacontane-Loaded Transethosomal Gel for Antimicrobial Treatment for Skin Infections
title_short Formulation Development, Optimization by Box–Behnken Design, and In Vitro and Ex Vivo Characterization of Hexatriacontane-Loaded Transethosomal Gel for Antimicrobial Treatment for Skin Infections
title_sort formulation development, optimization by box–behnken design, and in vitro and ex vivo characterization of hexatriacontane-loaded transethosomal gel for antimicrobial treatment for skin infections
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10137727/
https://www.ncbi.nlm.nih.gov/pubmed/37102934
http://dx.doi.org/10.3390/gels9040322
work_keys_str_mv AT aodahalhussainh formulationdevelopmentoptimizationbyboxbehnkendesignandinvitroandexvivocharacterizationofhexatriacontaneloadedtransethosomalgelforantimicrobialtreatmentforskininfections
AT hashmisana formulationdevelopmentoptimizationbyboxbehnkendesignandinvitroandexvivocharacterizationofhexatriacontaneloadedtransethosomalgelforantimicrobialtreatmentforskininfections
AT akhtarnaseem formulationdevelopmentoptimizationbyboxbehnkendesignandinvitroandexvivocharacterizationofhexatriacontaneloadedtransethosomalgelforantimicrobialtreatmentforskininfections
AT ullahzabih formulationdevelopmentoptimizationbyboxbehnkendesignandinvitroandexvivocharacterizationofhexatriacontaneloadedtransethosomalgelforantimicrobialtreatmentforskininfections
AT zafarameeduzzafar formulationdevelopmentoptimizationbyboxbehnkendesignandinvitroandexvivocharacterizationofhexatriacontaneloadedtransethosomalgelforantimicrobialtreatmentforskininfections
AT zakirandamohammed formulationdevelopmentoptimizationbyboxbehnkendesignandinvitroandexvivocharacterizationofhexatriacontaneloadedtransethosomalgelforantimicrobialtreatmentforskininfections
AT khanshamshir formulationdevelopmentoptimizationbyboxbehnkendesignandinvitroandexvivocharacterizationofhexatriacontaneloadedtransethosomalgelforantimicrobialtreatmentforskininfections
AT ansarimohammadjaved formulationdevelopmentoptimizationbyboxbehnkendesignandinvitroandexvivocharacterizationofhexatriacontaneloadedtransethosomalgelforantimicrobialtreatmentforskininfections
AT jawaidtalha formulationdevelopmentoptimizationbyboxbehnkendesignandinvitroandexvivocharacterizationofhexatriacontaneloadedtransethosomalgelforantimicrobialtreatmentforskininfections
AT alamaftab formulationdevelopmentoptimizationbyboxbehnkendesignandinvitroandexvivocharacterizationofhexatriacontaneloadedtransethosomalgelforantimicrobialtreatmentforskininfections
AT alimdsajid formulationdevelopmentoptimizationbyboxbehnkendesignandinvitroandexvivocharacterizationofhexatriacontaneloadedtransethosomalgelforantimicrobialtreatmentforskininfections